Company intelligence / Profile preview

Actum Pharma

King of Prussia, Pennsylvania, United Statesactumpharma.com ↗

Ownership: Private
Development stage: Other

Overview

Actum Pharma is a strategy and operating business partner for global biopharma manufacturers. The company specializes in helping life sciences organizations fund, develop, manage, and market novel therapies—especially those targeting rare and complex conditions—by providing business solutions that accelerate market success. It does not discover or develop its own drugs but works closely with C-suite leaders and investors to ensure successful commercialization of scientifically viable therapies that might otherwise fail due to avoidable missteps.

Therapeutic areas: OtherRare Diseases
Modalities: Small moleculeCell therapyGene therapy
Industry: Consulting

Partnerships

AscellaHealth LLCVarious biopharma manufacturers as clients

Beyond the preview

Go deeper on Actum Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actum Pharma.

Explore the full profile